Leveraging decades of experience in the healthcare industry and its subsectors, Simpson Thacher has been the preferred partner for a diverse array of leading companies, investment funds and financial advisors. We guide our clients in navigating the complexities of today’s business, scientific, regulatory and political trends.
Practice Group of the Year
Named a Law360 Health Care “Practice Group of the Year” for 2023
Whether we are advising on multibillion-dollar mergers, tackling major antitrust challenges or guiding clients through disputes and investigations, our healthcare group delivers results through industry-specific experience and leveraging a cross-practice, collaborative team.
We advise our clients on matters involving regulations administered and enforced by the U.S. Food and Drug Administration, the U.S. Department of Health and Human Services, U.S. Drug Enforcement Administration, the U.S. Treasury Department’s Office of Foreign Assets Control, the U.S. State Department, the U.S. Commerce Department’s Bureau of Industry and Security, and state laws and regulations.
We value, and know how to build, successful long-term relationships with our clients and work with them to anticipate challenges so that they can aggressively pursue market and business opportunities.
$1.3T+
More than $1.4 trillion aggregate value of healthcare deals since 2016 (LSEG)
640+
Over 640 corporate representations in healthcare since 2016 (LSEG)
“Simpson Thacher couples ‘an impressive level of experience, industry knowledge and business acumen’ with a ‘deep bench.’”
Our team represents clients across major healthcare and life sciences subsectors. We have recently advised on transactions such as:
Pharma/Biotech/Pharmacy
fiber_manual_record
Karuna Therapeutics, Inc.’s acquisition by Bristol-Myers Squibb Company, representing a total equity value of approximately $14 billion
fiber_manual_record
Underwriters/initial purchasers in the $6 billion debt offering by CVS Health, $5 billion notes offering by Roche and $2.25 billion debt offering by AstraZeneca
fiber_manual_record
PPD’s $17.4 billion acquisition by Thermo Fisher Scientific and its $1.863 billion IPO
fiber_manual_record
Valeant (n/k/a Bausch Health Companies) in high-profile securities fraud and RICO class actions, recently securing dismissals in multiple actions
fiber_manual_record
CSL in its acquisition of Vifor Pharma and the formation of the CoVIg-19 Plasma Alliance, and its acquisition of uniQure
fiber_manual_record
Pfizer’s $1 billion sustainability bond offering, earmarked for COVID-19 vaccine R&D, manufacturing and distribution
fiber_manual_record
EQT and Goldman Sachs Asset Management’s $8.5 billion acquisition of Parexel
fiber_manual_record
Syneos Health’s debt and equity offerings totaling approximately $3.4 billion
fiber_manual_record
10x Genomics’ $448.5 million IPO, the largest life sciences IPO of 2019
fiber_manual_record
Defense of Pfizer in multiple securities litigations
fiber_manual_record
Blackstone’s approximately $2.3 billion acquisition of Takeda Consumer Healthcare Company
fiber_manual_record
Nuvalent’s $165.75 million initial public offering
fiber_manual_record
Patricia Industries and Advanced Instruments in Advanced Instruments’ announced acquisition of Solentim
fiber_manual_record
Bayer and Pfizer in false advertising matters
MedTech & Devices
fiber_manual_record
Medline Inc. on its initial public offering, which raised total gross proceeds of more than $7 billion, the largest IPO of 2025 and the largest healthcare IPO in history
fiber_manual_record
Laborie Medical Technologies, Inc., a Patricia Industries portfolio company, in its strategic equity investment in Bright Uro, its $600 million acquisition of Urotronic, Inc. and its $5 million investment in GIE Medical, Inc.
fiber_manual_record
Teleflex Incorporated, a leading global provider of medical technologies, in its $2.03 billion sale of its Acute Care, Interventional Urology, and OEM businesses; its acquisition of Palette Life Sciences AB for $600 million upfront plus $50 million in milestone payments; and multiple other acquisitions and debt offerings
fiber_manual_record
Vyaire Medical, a portfolio company of funds advised by Apax Partners, in the sale of its consumables business to SunMed
fiber_manual_record
Avantor’s $4.37 billion IPO, the largest healthcare IPO in U.S. history, and multiple debt and equity offerings
fiber_manual_record
EQT VIII fund and Aldevron in connection with the sale of Aldevron to Danaher Corporation for an enterprise value of $9.6 billion
fiber_manual_record
New Mountain Capital’s $2.45 billion acquisition of PerkinElmer’s Applied, Food and Enterprise Services businesses
fiber_manual_record
Blackstone, Carlyle and Hellman & Friedman’s majority investment in Medline Industries
fiber_manual_record
KKR Biomet in dismissal of all claims in a putative securities class action
fiber_manual_record
Sotera Health’s $1.2 billion IPO
fiber_manual_record
Apria’s $172.5 million IPO, secondary offerings and $1.6 billion acquisition by Owens & Minor
fiber_manual_record
Financing for Baxter International’s acquisition of Hillrom
fiber_manual_record
Debt offerings for Boston Scientific, AdaptHealth and Agilent Technologies
fiber_manual_record
Bioventus’ $120 million initial public offering
fiber_manual_record
A medical device company in connection with allegations raised relating to FDA and FCPA compliance issues
fiber_manual_record
PHC Holdings’ $1.14 billion acquisition of the Anatomical Pathology business of Thermo Fisher
fiber_manual_record
Avantor’s $2.9 billion acquisition of the Masterflex bioprocessing business and related assets of Antylia Scientific
fiber_manual_record
Laborie Medical Technologies’ acquisition of Pelvalon
Payors & Providers
fiber_manual_record
BrightSpring Health Services, Inc. in its $1.1 billion IPO
fiber_manual_record
Cigna’s debt offerings, totaling more than $10.3 billion
fiber_manual_record
KKR in its acquisition of PharMerica, Covenant Surgical Partners, PetVet Care Centers, a majority interest in Heartland Dental, and merger between 123Dentist, Altima Dental and Lapointe Group
fiber_manual_record
21st Century Oncology in a civil suit alleging monopolization and attempted monopolization in violation of Sherman Act Section 2
fiber_manual_record
Bright Health Group’s $924.3 million initial public offering
fiber_manual_record
Buyer consortium in a going-private transaction of New Frontier Corporation, operator of United Family Healthcare
fiber_manual_record
Debt offerings for Community Health Systems, Humana, UnitedHealth Group, Voyage Care and Universal Health Services
fiber_manual_record
HCA’s IPO and multiple debt and equity offerings
fiber_manual_record
InnovAge’s $350 million IPO
fiber_manual_record
Apax’s acquisition of Eating Recovery Center
fiber_manual_record
Blackstone Tactical Opportunities’ financing for the acquisition of a majority stake in Deca Dental Group
fiber_manual_record
HCA in the resolution of a class-action lawsuit alleging that three defendant hospital networks conspired to depress nurse wages
fiber_manual_record
A national healthcare provider in a criminal antitrust “no-poach” investigation
fiber_manual_record
An insurance carrier concerning a computer data access incident that resulted in investigations by various state and federal government and regulatory entities, including the Department of Health and Human Services and the DOJ
Healthcare IT & Services
fiber_manual_record
Amedisys in favorably resolving DOJ litigation attempting to block its $3.3 billion acquisition by UnitedHealth Group
fiber_manual_record
Waystar Holding Corp. in its $1.25 billion acquisition of Iodine Software, a leader in AI-powered clinical intelligence
fiber_manual_record
Change Healthcare’s $13.8 billion acquisition by UnitedHealth and its $928 million IPO and concurrent equity offering
fiber_manual_record
WW International’s $132 million acquisition of Sequence
fiber_manual_record
McKesson’s $875 millionacquisition of Rx Savings Solutions
fiber_manual_record
Microsoft’s $19.7 billion acquisition of Nuance Communications, Inc.
fiber_manual_record
Air Medical Group Holdings’, a KKR portfolio company, acquisition of American Medical Response
fiber_manual_record
McKesson in the dismissal of an antitrust class action concerning an alleged price-fixing conspiracy among manufacturers of generic pharmaceuticals
fiber_manual_record
Waystar’s acquisition of HealthPay24
fiber_manual_record
MultiPlan’s $11 billion merger with Churchill Capital Corp III
fiber_manual_record
Certara’s $768.5 million IPO, $310 million acquisition of Pinnacle 21 and acquisition of Insight Medical Writing
fiber_manual_record
Waystar’s $1.35 billion acquisition of eSolutions and acquisition of Patientco
fiber_manual_record
Signify Health’s $648.6 million IPO
fiber_manual_record
Hellman & Friedman’s minority strategic investment in PointClickCare Technologies
fiber_manual_record
EQT’s acquisition of a 20% stake in 3Shape
fiber_manual_record
BlackRock Long Term Private Capital’s acquisition of a majority interest in Transaction Data Systems
fiber_manual_record
Weight Watchers in securing a dismissal of a securities class action alleging false and misleading statements regarding its financial performance
fiber_manual_record
EQT’s $2.7 billion acquisition with CPPIB of a majority stake in Waystar